Categories: News

Virbac : Declaration of the number of shares and voting rights 03/2024

DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS

Information on the total number of voting rights and of shares representing the share capital
(Article 223-16 of the General regulations of the French Financial Market Authority – Autorité
des Marchés Financiers)

Quotation place: Euronext Paris
Compartiment A
ISIN code: FR0000031577

Date Total number of shares representing the share capital Total number of voting rights
March, 31 2024 8 458 000 Gross total of voting rights : 12 780 944
Net total* of voting rights : 12 692 663

Net total* = total number of voting rights attached to the total number of shares net of shares with no voting rights.

VIRBAC: Shaping the future of animal health
NYSE Euronext – Compartiment A / Code ISIN: FR0000031577 / MNEMO: VIRP
Corporate Finance: tel. 33 4 92 08 71 32 / Email: finances@virbac.com
Website: www.virbac.com

Attachment

Staff

Recent Posts

NervGen Pharma Announces Proposed Amendment to Warrants

Vancouver, British Columbia--(Newsfile Corp. - December 12, 2025) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB:…

3 hours ago

MyndTec Inc. Completes Ninth Tranche of Non-Brokered Private Placement

Mississauga, Ontario--(Newsfile Corp. - December 12, 2025) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"),…

5 hours ago

Dominari Holdings Announces Change of Record Date and Payment Date for $10 Million Cash Dividend

NEW YORK, Dec. 12, 2025 /PRNewswire/ -- Dominari Holdings Inc. (Nasdaq: DOMH) is pleased to announce…

5 hours ago

ISHI Health Launches Virtual Heart Failure Clinics in California and Arizona

SAN DIEGO, Dec. 12, 2025 /PRNewswire/ -- ISHI Health, an innovator in AI-enabled virtual cardiac…

5 hours ago

Zealthy Review 2026: How Zealthy Compares to FitRx and RoenRx for Weight Loss & GLP-1 Care

LOS ANGELES, CA / ACCESS Newswire / December 12, 2025 / The landscape of weight…

5 hours ago

Aspire Biopharma Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements

ESTERO, FL / ACCESS Newswire / December 12, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP)…

5 hours ago